UB Paderborn / Katalog / Suche / in CDI

Refractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy

Scandinavian journal of rheumatology, 2022-05, Vol.51 (3), p.237-240

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunology and the diagnosis of lupus nephritis

Lupus, 2009-04, Vol.18 (4), p.287-290

2009

Link zum Volltext

Verfügbarkeit prüfen

POS-053 90-day post-hospital follow-up in survivors after COVID-19-associated acute kidney injury requiring kidney replacement therapy

Kidney international reports, 2021-04, Vol.6 (4), p.S24-S24

2021

Link zum Volltext

Verfügbarkeit prüfen

AB0129 Mechanisms of t cell recruitment in lupus nephritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A825-A825

2013

Link zum Volltext

Verfügbarkeit prüfen

SAT0182 Urinary T cells identify SLE patients with proliferative lupus nephritis and may be used to monitor treatment response

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.533-533

2013

Link zum Volltext

Verfügbarkeit prüfen

T cell cytokine imbalance towards production of IFN-γ and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis

Scandinavian journal of rheumatology, 2006-05, Vol.35 (3), p.209-216

2006

Link zum Volltext

Verfügbarkeit prüfen

Tubular Epithelial Cell HMGB1 Promotes AKI-CKD Transition by Sensitizing Cycling Tubular Cells to Oxidative Stress: A Rationale for Targeting HMGB1 during AKI Recovery

Journal of the American Society of Nephrology, 2023-03, Vol.34 (3), p.394-411

2023

Link zum Volltext

Verfügbarkeit prüfen

Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: An experimental mouse study

Lupus, 2011-10, Vol.20 (12), p.1240-1249

2011

Link zum Volltext

Verfügbarkeit prüfen

P47 THE ANTIRENAL AUTOREACTIVE CD4+ T CELL RESPONSE IN HUMAN LUPUS NEPHRITIS

Kidney international reports, 2016-11, Vol.1 (4), p.S21-S22

2016

Link zum Volltext

Verfügbarkeit prüfen

P42 URINARY CELL SIGNATURE OF PATIENTS WITH ACUTE KIDNEY INJURY

Kidney international reports, 2016-11, Vol.1 (4), p.S19-S20

2016

Link zum Volltext

Verfügbarkeit prüfen

P45 IL-2 THERAPY REDUCES RENAL INFLAMMATION AND CELLULAR ACTIVITY OF INTRARENAL CD4+ CONVENTIONAL T CELLS IN LUPUS PRONE MICE WITH ACTIVE LUPUS NEPHRITIS

Kidney international reports, 2016-11, Vol.1 (4), p.S20-S21

2016

Link zum Volltext

Verfügbarkeit prüfen

What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3

Clinical and experimental rheumatology, 2017-07, Vol.35 (4), p.598

2017

Link zum Volltext

Verfügbarkeit prüfen

A2.17 Detection of autoantigen-specific CD4+ T cells associated with systemic lupus erythematosus

Annals of the rheumatic diseases, 2016-02, Vol.75 (Suppl 1), p.A22-A22

2016

Link zum Volltext

Verfügbarkeit prüfen

T cell cytokine imbalance towards production of IFN- and IL-10 in NZB W F1 lupus-prone mice is associated with autoantibody levels and nephritis

Scandinavian journal of rheumatology, 2006-05, Vol.35 (3), p.209-216

2006

Link zum Volltext

Verfügbarkeit prüfen

The systemic and SmD183-119-autoantigen-specific cytokine memory of Th cells in SLE patients

Rheumatology (Oxford, England), 2007-02, Vol.46 (2), p.238-245

2007

Link zum Volltext

Verfügbarkeit prüfen

A6.10 A biomarker discovery approach for urinary cells in lupus nephritis

Annals of the rheumatic diseases, 2016-02, Vol.75 (Suppl 1), p.A51-A51

2016

Link zum Volltext

Verfügbarkeit prüfen

A7.06 Low-dose IL-2 therapy in refractory sle: Insights from a phase I/IIA clinical trial

Annals of the rheumatic diseases, 2016-02, Vol.75 (Suppl 1), p.A58-A58

2016

Link zum Volltext

Verfügbarkeit prüfen

Akutes pulmorenales Syndrom auf der Intensivstation: Rationale Diagnostik und Therapie

Der Nephrologe, 2019-11, Vol.14 (6), p.438-445

2019

Link zum Volltext

Verfügbarkeit prüfen

Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus

Annals of the rheumatic diseases, 2011-12, Vol.70 (12), p.2176-2183

2011

Link zum Volltext

Verfügbarkeit prüfen

CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients

Arthritis and rheumatism, 2009-01, Vol.60 (1), p.199-206

2009

Link zum Volltext

Verfügbarkeit prüfen

THU0195 IFNα and its response proteins IP-10 and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.221-221

2013

Link zum Volltext

Verfügbarkeit prüfen

THU0195 IFN[alpha] and its response proteins IP-10 and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus

Annals of the rheumatic diseases, 2013-06, Vol.71, p.221

2013

Link zum Volltext

Verfügbarkeit prüfen

Intravenous Injection of a D1 Protein of the Smith Proteins Postpones Murine Lupus and Induces Type 1 Regulatory T Cells

The Journal of immunology (1950), 2004-11, Vol.173 (9), p.5835-5842

2004

Link zum Volltext

Verfügbarkeit prüfen

The cytokine memory of SmD183-119-autoantigen-specific Th cells of systemic lupus erythematosus patients

Arthritis research & therapy, 2005, Vol.7 Suppl 1 (Suppl 1), p.P97-P97

2005

Link zum Volltext

Verfügbarkeit prüfen

Induction of pathogenic anti-dsDNA antibodies is controlled on the level of B cells in a non-lupus prone mouse strain

Journal of clinical immunology, 2006-01, Vol.26 (1), p.86-95

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Refractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy

Immunology and the diagnosis of lupus nephritis

POS-053 90-day post-hospital follow-up in survivors after COVID-19-associated acute kidney injury requiring kidney replacement therapy

AB0129 Mechanisms of t cell recruitment in lupus nephritis

SAT0182 Urinary T cells identify SLE patients with proliferative lupus nephritis and may be used to monitor treatment response

T cell cytokine imbalance towards production of IFN-γ and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis

Tubular Epithelial Cell HMGB1 Promotes AKI-CKD Transition by Sensitizing Cycling Tubular Cells to Oxidative Stress: A Rationale for Targeting HMGB1 during AKI Recovery

Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: An experimental mouse study

P47 THE ANTIRENAL AUTOREACTIVE CD4+ T CELL RESPONSE IN HUMAN LUPUS NEPHRITIS

P42 URINARY CELL SIGNATURE OF PATIENTS WITH ACUTE KIDNEY INJURY

P45 IL-2 THERAPY REDUCES RENAL INFLAMMATION AND CELLULAR ACTIVITY OF INTRARENAL CD4+ CONVENTIONAL T CELLS IN LUPUS PRONE MICE WITH ACTIVE LUPUS NEPHRITIS

What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3

A2.17 Detection of autoantigen-specific CD4+ T cells associated with systemic lupus erythematosus

T cell cytokine imbalance towards production of IFN- and IL-10 in NZB W F1 lupus-prone mice is associated with autoantibody levels and nephritis

The systemic and SmD183-119-autoantigen-specific cytokine memory of Th cells in SLE patients

A6.10 A biomarker discovery approach for urinary cells in lupus nephritis

A7.06 Low-dose IL-2 therapy in refractory sle: Insights from a phase I/IIA clinical trial

Akutes pulmorenales Syndrom auf der Intensivstation: Rationale Diagnostik und Therapie

Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus

CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients

THU0195 IFNα and its response proteins IP-10 and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus

THU0195 IFN[alpha] and its response proteins IP-10 and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus

Intravenous Injection of a D1 Protein of the Smith Proteins Postpones Murine Lupus and Induces Type 1 Regulatory T Cells

The cytokine memory of SmD183-119-autoantigen-specific Th cells of systemic lupus erythematosus patients

Induction of pathogenic anti-dsDNA antibodies is controlled on the level of B cells in a non-lupus prone mouse strain

Suchergebnisse filtern